Filter by: patients
Home > Evaluations from Patients who take Dalfampridine (4-AP extended release)

Dalfampridine (4-AP extended release) Treatment Report

Category: Prescription Drugs

Most Popular Types: Ampyra

false

See also: Fampridine (4-AP immediate release)

Sort by: Helpfulness | Most Recent

3 patient evaluations for Dalfampridine (4-AP extended release) taken for the purpose of 'MS (Multiple Sclerosis)' with a side effects rating of SevereSevereSevereSevereSevere

Purposes: Chronic Fatigue Syndrome and MS (Multiple Sclerosis) (Started Jul 01, 2012)
Date Dosage Chronic Fatigue Syndrome Perceived effectiveness MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Jul 18, 2012 1 other Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major SevereSevereSevereSevereSevere AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks
Purposes: Walking problems, Improve flexibility/strength, and MS (Multiple Sclerosis) (Started Jul 15, 2010)
Date Dosage Walking problems Perceived effectiveness Improve flexibility/strength Perceived effectiveness MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Feb 03, 2012 20 mg Daily Led_efficacy_1Led_defaultLed_defaultLed_default Led_efficacy_1Led_defaultLed_defaultLed_default Led_efficacy_1Led_defaultLed_defaultLed_default SevereSevereSevereSevere UsuallyUsuallyUsuallyUsually Not at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks
Purposes: MS (Multiple Sclerosis) and Walking problems (Started Mar 01, 2011)
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Walking problems Perceived effectiveness Side Effects Adherence Burden
Sep 15, 2011   Led_efficacy_1Led_defaultLed_defaultLed_defaultNone Led_efficacy_1Led_defaultLed_defaultLed_defaultNone SevereSevereSevereSevereSevere UsuallyUsuallyUsuallyUsuallyUsually Not at allNot at allNot at allNot at allNot at all
Date
Sep 15, 2011
Advice & Tips
when a flare- up begins, check with your doctor immediately. it may be the Ampyra as it causes flare-ups.
Cost
< $25 monthly
  • Icon_thumb_on 1 helpful mark

10 additional evaluations for Dalfampridine (4-AP extended release) are not currently shared publicly.